Oil and drugs barons lead the dollar romp
Chevron and AstraZeneca led a dash for dollars this week as issuers made the most of favourable funding conditions in what is expected to be a heavy month for high grade supply.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts